Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial
mohamed_hassan / Pixabay

Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial

According to a story from BioPortfolio, AstraZeneca and Merck have recently announced the results from a phase 3 clinical trial testing olaparib (marketed as LYNPARZA®) as a treatment for BRCA…

Continue Reading Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial
New Collaboration Will Test Live Biotherapeutics Against Different Cancers
geralt / Pixabay

New Collaboration Will Test Live Biotherapeutics Against Different Cancers

According to a story from finanznachrichten.de, the biotherapeutics company 4D pharma has recently announced a research partnership with the MD Anderson Cancer Center at the University of Texas. The goal of…

Continue Reading New Collaboration Will Test Live Biotherapeutics Against Different Cancers

CRISPR Uncovers New Gene Fusion as Novel Drug Target for Brain, Ovarian and other Cancers

  CRISPR-Cas9, the genome editing tool, has caused quite a stir in the scientific community. According to a recent article in Science Daily, with results published in Nature Communications, CRISPR has…

Continue Reading CRISPR Uncovers New Gene Fusion as Novel Drug Target for Brain, Ovarian and other Cancers
Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?
qimono / Pixabay

Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

According to a story from globenewswire.com, the biopharmaceutical company Innovation Pharmaceuticals recently released a report in which recent studies and pre-clinical research has suggested that the company's experimental drug Kevetrin…

Continue Reading Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

Orphan Drug Designation Granted for Potential Duchenne Muscular Dystrophy Treatment

For years FibroGen has been investigating a drug called pamrevlumab. They believe it could be an effective treatment for Duchenne muscular dystrophy (DMD), pancreatic cancer, and idiopathic pulmonary fibrosis (IPF).…

Continue Reading Orphan Drug Designation Granted for Potential Duchenne Muscular Dystrophy Treatment
Experimental Cancer Drug Displays Potential in a Number of Rare Cancers
MALCOLUMBUS / Pixabay

Experimental Cancer Drug Displays Potential in a Number of Rare Cancers

According to a story from EurekAlert!, a new type of cancer drug that is being described as a "Trojan horse" that infiltrates cancer tumors is showing potential in several types…

Continue Reading Experimental Cancer Drug Displays Potential in a Number of Rare Cancers
This Research Partnership Will Investigate the Relationship Between Obesity and Pancreatic Cancer
Films42 / Pixabay

This Research Partnership Will Investigate the Relationship Between Obesity and Pancreatic Cancer

According to a story from prweb.com, researchers from the Johns Hopkins Kimmel Cancer Center and the Allegheny Health Network (AHC) Cancer Institute have entered a partnership that plans to investigate…

Continue Reading This Research Partnership Will Investigate the Relationship Between Obesity and Pancreatic Cancer
‘Stand Up to Cancer’ Donates $1 Million to Help Develop Efficient Pancreatic Cancer Treatment
source: pixabay.com

‘Stand Up to Cancer’ Donates $1 Million to Help Develop Efficient Pancreatic Cancer Treatment

Stand Up To Cancer (SU2C) has donated a million dollars for a research project dedicated towards a new way of deploying the immune system against pancreatic cancer. This is welcome…

Continue Reading ‘Stand Up to Cancer’ Donates $1 Million to Help Develop Efficient Pancreatic Cancer Treatment